Back to search

Article

Circulating extracellular vesicle-based multianalyte biomarker signatures accurately distinguish glioblastoma from brain metastasis patients before surgery

2025-04-14

Abstract excerpt

Distinguishing glioblastoma (GBM) from secondary brain metastases (BMET) remains a common diagnostic challenge due to overlapping radiographic features and diverse clinical presentations. Non-invasive liquid biopsies offer a promising alternative to image-based diagnostics to guide neoadjuvant treatments and improve patient outcomes. Extracellular vesicles (EVs), membranous nanoparticles, serve as valuable biomark...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
55eba7f2-c04c-55be-9a97-8e70ab4c616d
DOI
10.22541/au.174465021.16864881/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating extracellular vesicle-based multianalyte biomarker signatures accurately distinguish glioblastoma from brain metastasis patients before surgeryDOI 10.22541/au.174465021.16864881/v1
Select a neighboring publication to make it the new centre.